SAN DIEGO, Jan. 24, 2017 — BioSurplus, America’s preeminent buyer and reseller of preowned lab equipment, has appointed Theresa Matkovits, Ph.D., and Tina Lai Liedtky to its board of directors, bringing in two executives with deep experience that spans the pharmaceutical and medical device industries.
“The knowledge that Dr. Matkovits and Ms. Lai Liedtky bring to our board will be incredibly valuable as we continue to expand our offerings to life science companies and universities,” said Bill VanDeWeghe, President and Chief Executive Officer of BioSurplus. “Our new board members bring a sophisticated level of industry knowledge and experience that will help us better serve our customers.”
Theresa Matkovits has global drug development and commercialization leadership experience spanning global, multinational pharmaceutical companies to small biotech start-ups. She currently serves as Senior Vice President, Head of Drug Development at ContraVir Pharmaceuticals Inc., where she leads the world-wide development activities for the company’s antiviral pipeline. Theresa has previously held numerous worldwide, international drug development leadership roles at Novartis, The Medicines Company, and NPS Pharmaceuticals, which encompassed leading the successful development and registration of a number of now globally commercialized medicines in the antiinfective, CNS, and orphan disease areas. Theresa was recently selected to participate in Women in Bio’s “Boardroom-Ready Program” for executive women in Life Sciences, sponsored by George Washington University. Theresa is a board member for Center Point Clinical Services LLC, a specialty contract research organization for pharmaceutical and medical device companies. She holds a doctorate degree in Biochemistry and Molecular Biology from the University of Medicine and Dentistry of New Jersey, and a Bachelor of Arts degree in Biology from Alfred University.
Tina Lai Liedtky has broad experience building, growing, and managing large operations within the medical device and diagnostics industries. She currently serves as Vice President, Global Marketing and Product Development of the Cardiometabolic business unit at Alere Inc., which develops rapid diagnostic tests to improve health and economic outcomes. She has also served as Vice President, Global Marketing at Lombard Medical Inc. and Senior Director of Sales and Marketing at Covidien. She is a board member of the Harvard Business School Alumni Club of San Diego; was an advisory board member of the Michael Hoefflin Foundation, which focuses on childhood cancer; and founded Social Capital Philanthropists, an organization supporting grassroots philanthropy. Ms. Lai Liedtky received her Master of Business degree in Business Administration and Management from Harvard Business School, and a Bachelor of Arts degree in Psychology from Princeton University.
Founded in 2002, BioSurplus is America’s preeminent buyer and reseller of preowned lab equipment. Customers can shop from anywhere using the BioSurplus online store, online auctions or visit us in California in one of our two showrooms. BioSurplus purchases late model working lab instruments from labs that no longer need them, and then passes on the savings of repurposed equipment to its customers. The BioSurplus team is carefully chosen for their scientific experience and background to ensure the proper marketing, selling and handling of a wide range of laboratory instruments. BioSurplus is dedicated to maximizing the value and use of laboratory equipment for both its buying and selling customers.
BioSurplus is headquartered in San Diego and has lab equipment showrooms and warehouses in San Diego and San Francisco. For more information, please visit our website at www.BioSurplus.com.